EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineered B7‐H3 Binding in Modular Gp2 Miniproteins

Abbigael Harthorn, Hannah K Windsor, Zachary Schmitz, Nathaniel Cheung, Ebube Agwaramgbo, Benjamin J Hackel

Biotechnology and Bioengineering · 2026

DOI: 10.1002/bit.70221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Bioengineering, 2026. Verfasst von Abbigael Harthorn und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Minnesota - Twin Cities, Minneapolis, MN, USA. Hauptthemen laut MEDLINE: B7 Antigens, Protein Engineering. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

B7‐H3, an important immune checkpoint modulator of T‐cell function, is a tumor vasculature biomarker and is overexpressed in a variety of cancers. Its expression is associated with tumor growth, metastasis, and poor clinical prognosis, which makes B7‐H3 an appealing target for diagnostics and therapeutics. High‐affinity, specific, modular ligands are needed to achieve the various modes of molecular targeting strategies. A designed combinatorial library of the small (45 amino acid) Gp2 scaffold was sorted for binders to B7‐H3 via yeast surface display with magnetic and flow cytometric cell sorting. Select variants were sequenced, characterized for binding affinity and specificity to B7‐H3, and assessed for modularity in a protein‐protein fusion. Protein ligands achieved single‐digit nanomolar affinities and retained binding affinity upon conjugation, via a glycine‐rich linker, to an enzyme. Directed evolution resulted in a potent, 0.7 nM binder with increased stability as assessed through the apparent midpoint of denaturation of 67°C. The engineered ligands provide small, modular, high‐affinity B7‐H3 binders for molecularly targeted therapeutics and diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7 AntigensProtein EngineeringProtein BindingHumansDirected Molecular Evolution

Stichwörter der Autor:innen

B7‐H3Gp2affinity maturationdirected evolutionligandminiproteinstability

Substanzen

B7 AntigensCD276 protein, human

Autor:innen und Institutionen

  • Department of Biomedical Engineering, University of Minnesota - Twin Cities, Minneapolis, MN, USA.
  • Department of Chemical Engineering and Materials Science, University of Minnesota - Twin Cities, Minneapolis, MN, USA.

Förderung

  • NIGMS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Harthorn, A., Windsor, H. K., Schmitz, Z., Cheung, N., Agwaramgbo, E., & Hackel, B. J. (2026). Engineered B7‐H3 Binding in Modular Gp2 Miniproteins. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70221

Vancouver

Harthorn A, Windsor HK, Schmitz Z, Cheung N, Agwaramgbo E, Hackel BJ. Engineered B7‐H3 Binding in Modular Gp2 Miniproteins. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70221

BibTeX
@article{Harthorn2026,
  author = {Harthorn, Abbigael and Windsor, Hannah K and Schmitz, Zachary and Cheung, Nathaniel and Agwaramgbo, Ebube and Hackel, Benjamin J},
  title = {Engineered B7‐H3 Binding in Modular Gp2 Miniproteins},
  journal = {Biotechnology and Bioengineering},
  year = {2026},
  doi = {10.1002/bit.70221}
}
Kostenlos starten →